http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H1160483-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95acaa82b3c3574721242345723fd65c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D489-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1997-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_981556784101febc479f3323b3b7c0d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dcacdbaa127d1c91ebd176bc13b8dc9
publicationDate 1999-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H1160483-A
titleOfInvention TNF production inhibitor
abstract (57) [Problem] To provide a novel TNF production inhibitor. Kind Code: A1 Abstract: Formula (I) (Wherein, R 1 represents a hydrogen atom or a lower alkanoyl group, and R 2 represents a lower alkanoyl group) or a pharmaceutically acceptable acid addition salt thereof as an active ingredient. Inhibitors. The morphine derivative (I) or a pharmacologically acceptable acid addition salt thereof is useful as a therapeutic agent for diseases accompanied by abnormal production of TNF.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015155449-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1402899-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2987788-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02089845-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7652025-B2
priorityDate 1997-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549121
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID554167
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395290
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID36054
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID494186
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449097368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453865105
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID114461
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100126739
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID744399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288826

Total number of triples: 42.